Crotamiton - An effective and safe drug for the treatment of scabies results of a controlled clinical trial;Crotamiton - Eine wirksame und sichere substanz fur die therapie der skabies. Ergebnisse einer kontrollierten klinischen profung

H+G Zeitschrift fur Hautkrankheiten

Volumn 74, Issue 3, 1999, Pages 162-166

  Tausch, I ^a  

^a Hautarztpraxis ^*  (Germany)

Author keywords

Controlled clinical study; Crotamiton; Efficacy; Scabies

Indexed keywords

CROTAMITON;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SARCOPTES SCABIEI; SCABIES;

EID: 0032893643     PISSN: 03010481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Agathos, M (1994): Skabies Hautarzt 45, 889-903.
2. Appel B. (1950). The treatment of scabies in an institution: comparative study. New Engl. J. Med., 243, 74-76.
3. BiosKin Institut fur Dermatologische Forschung und Entwicklung GmbH, Hamburg; Ergebnisse unveroffentlichter kontrollierter klinischer Prüfungen (1997).
4. Balfanz U. (1978): Antiprunginosum auch bei Skabies effektiv Arztl. Praxis, 10, 245-247.
5. Boffa, M. J., P. A., Brough, R. D. Ead (1995): Undane neurotoxicity Brit. J Dermatology 113, 1013.
6. Couperus M. (1949): The use of n-ethyl-o-crotono-toluidide in the treatment of scabies and various pruritic dermatoses. J. Invest. Dermat. 13, 35-42
7. Crotamiton. Monographie: Bundesanzeiger Nr. 132, 1993
8. Cubela V. (1978). Clinical experience with crotamiton cream and lotio in treatment of infants with scabies. Brit. J. Clin. Pract. 32, 229-231.
9. Dani N R. (1949): Observations with Eurax in treatment of scabies Medical Digest, 17, 429-434.
10. Domenjoz R. (1946): Über em neues Antiscabiosum. Schweiz. Med. Wschr., 47, 1210-1213
11. Domer G (1949): Über das neue Antiscabiosum Eurax. Dtsch. med. Rdschau, 3, 422-424.
12. Elgart M. L. (1996): A risk-benefit assessment of agents used in treatment of scabies. Drug Saf. 14, 386-393.
13. Hausen B.M., J. Kriskin (1988): The sensitizing capacity of crotamiton. Contact Dermatitis, 18, 298-299.
14. Hitch J. M. (1952): An evaluation of N-ethyl-o crotonotoluide as an antipruritic. Br. J. Dermatol, 64, 408-416
15. Ippen, H, W. Uter (1991): Alte und neue Dermatika. Verwendung von Antimikrobika und Antiparasitika in mitteleuropaischen Kliniken. Dermatosen 39, 7-11.
16. Johnson S. A M., J. Bringe (1951): Use of N-Ethyl-O-Crotonotoluidide for the relief of pruritus. J. W. Arch. Derm. Syph. Chicago, 63, 768.
17. Jung, E G. (1980): Scabies. Act. dermatol. 6, 77-84.
18. Karacic, I., S. J. Yawalkar (1982): A single application of crotamiton in the treatment of patients with pediculosis capitis. Int. J. Derm. 21, 611-613.
19. Konstantinov D., L. Stanoeva, S. J. Yawalkar (1979): Crotamiton cream and lotion in the treatment of infants and young children with scabies. J. Int. Med. Res., 7, 443-448.
20. Kreusch, J. F., H. H. Wolff (1995/96); Diagnose und Ausschluß der Skatnes bei Kindern durch Auflichtmikroskopie. Pádiat. prax. 50, 103-110.
21. Kwoczek J. (1951): Beitrag zur Lokalbehandlung des Juckreizes. Hautarzt, 2, 506-512.
22. Rass, G. (1995): Behandlung von Skabies in der àrztlichen Praxis mit Crotamitex, documenta biochemica biomo 26-30.
23. Rass, G. (1995). Die Behandlung von Pruritus verschiedener Ursache mit Crotamiton, documenta biomedica biomo 32-34.
24. Renault-Steens (1978): Five years use in the treatment of scabies in Senegal. Afr. med. 159, 289-292.
25. Schuster, O., G. Menke, H. Czichowsky, D. Loew (1992): Pharmacokinetics of crotamiton following topical application in healthy. J. Dermatol. Treatment 3, 57-60.
26. Taplin D , T.L. Meinking, J.A. Chen, R. Sanchez (1990): Comparison of crotamiton 10% cream (Egrax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatric Dermatology, 7, 67-73.